Navigation Links
China Kangtai Participates in 2007 China National Sugar and Wine Products Trade Fair
Date:10/19/2007

HARBIN, China, Oct. 19 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Bio-tech, Inc. (OTC Bulletin Board: CKGT) participated as an exhibitor in the 2007 National Sugar and Wine Products Trade Fair held in Harbin, China from October 11th through October 15th.

The National Sugar and Wine Products Trade Fair is the largest tradeshow for food and beverage products that contain sugar and alcohol in China. This year's event was unprecedented, with over 100,000 exhibitors and more than 200,000 visitors.

China Kangtai's exhibit highlighted a total of 30 its products in four different categories. Customer response was very positive and the Company received sales orders for over 40 million RMB of product to be fulfilled over the coming year. In addition, the Company received indications of interest from a number of potential customers with whom the Company plans to follow up over the coming weeks.

The Company believes that participating in this event has significantly increased its name recognition expanded the distribution channels for its products, and enabled the Company to begin to develop relationships with potential business partners. The Company plans to participate in similar tradeshows both in China and internationally.

The positive response at this tradeshow also confirmed the Company's belief in the potential market for its cactus-based products in China. The Company is confident that this event will have long term positive benefits for its business that will help ultimately deliver higher returns to its shareholders.

About Cactus and Its Derivative Products

According to The Grand Dictionary of Chinese Medicine and the Compendium of Materia Medica, as well as many certified tests and analyses carried out by the Department of Agriculture and the Institute for Nutrition and Food Safety of the Center of Disease Prevention and Control of China, cacti contain over 18 kinds of amino acid, carbohydrates, chief meal fibrin, carotene, vitamin C, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium, phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc, iodine, and selenium. Various cactus products have been shown to provide health benefits and have been used to treat a variety of health issues including, diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity, and various skin disorders.

China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 31 product patents, 15 of which have already been approved. It currently produces and sells four cactus-based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 36 existing products under these four categories.

Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, ''Cactus-based products are well received by the market in China and show huge growth potential. China Kangtai will continue to develop new products to meet the demand of the consumers, while penetrating the markets with its existing products.''

Wang concluded, ''Our Company remains focused on the quality and functionality of our products that deliver various health benefits to consumers. These new products will contribute positively to the Company's 2007 performance and beyond, and accelerate its revenue and profit growth. With 15 product patents and 16 pending approval, China Kangtai is the dominant player in the cactus-based consumer product sector."

About China Kangtai Cactus Bio-Tech Inc.

China Kangtai Cactus Bio-Tech, Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 16 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 14 provinces and 4 municipalities.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.

This forward-looking information should be considered only in connection with "Risk Factors" in China Kangtai Cactus Bio-tech's annual report on Form 10KSB filed with the SEC on April 2, 2007, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.

For more information, please contact:

At the Company:

Ren Hu

Vice President

China Kangtai Cactus Bio-tech, Inc.

Tel: +1-201-887-0415

Email: Arenhu@gmail.com

Web: http://www.biocactus.com

Investor Relations:

Jon Cunningham

RedChip Companies, Inc.

Tel: +1-800-RedChip x107

Email: Jon@RedChip.com or Info@RedChip.com

Web: http://www.RedChip.com


'/>"/>
SOURCE China Kangtai Cactus Bio-tech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: